Panama Country Profile
Since 2003, the CDC Central American Regional Office has been working with Ministries of Health and the Council of Health Ministers of Central America to respond to the HIV epidemic in the region. CDC works closely with the Government of Panama and other key partners to: expand effective HIV testing and counseling strategies; link newly diagnosed individuals to treatment; intensify tuberculosis case finding and preventive treatment among people living with HIV; implement early treatment initiation and differentiated service delivery models; and strengthen laboratory, health information, and surveillance systems.
Per Capita GNI
Under 5 Mortality
14.3/1,000 Live Births
TB Treatment Success Rate
Estimated TB Incidence
TB patients with known HIV-status who are HIV-positive
Reported Number Receiving Antiretroviral Therapy (ART)
Active Strategic Scale-up of Comprehensive HIV Services: The Centers for Disease Control and Prevention (CDC) office in Nigeria was established in February 2001, and provides technical leadership and assistance to the Ministry of Health (MOH) and implementing partners to scale up HIV testing, treatment, and prevention of mother-to-child transmission of HIV (PMTCT) services.
Strengthening Laboratory Systems and Networks: CDC provides technical leadership and assistance to build in-country capacity for high-quality HIV and Tuberculosis (TB) diagnostic and monitoring, and to support the development of a national reference public health laboratory system for HIV, TB, and other diseases.
Strengthening Public Health Systems: CDC assists the MOH to strengthen epidemiology, surveillance, laboratory, medical informatics, operations research, and workforce capacity – essential components for a strong, sustainable public health system.
Key Activities and Accomplishments
Prevention of Mother-to-Child HIV Transmission (PMTCT) Support: Working with local stakeholders and partners, 1,702 sites offering PMTCT services were established between October 2016 and September 2017. According to PEPFAR Nigeria data, between October 2016 and September 2017, HIV testing and counseling were provided to about 1 million pregnant women and antiretroviral therapy (ART) to 24,445 HIV-positive pregnant women to prevent mother-to-child transmission.
HIV Testing Services (HTS) and Antiretrovirus Treatment (ART) Services: CDC, through its implementing partners, provides high quality HIV testing services and HIV treatment and support services. Between October 2016 and September 2017, CDC and its partners provided HIV testing services to about 5 million people across Nigeria. Of this, 109,275 were diagnosed with HIV infection and referred for treatment. (PEPFAR Nigeria, 2017) At the end of FY17 (September 30, 2017), 480,207 patients were receiving ART, while almost 250,000 Orphan and Vulnerable Children were provided with a minimum of one care service in the last quarter of FY17. (PEPFAR Nigeria, 2017)
TB/HIV Integration: CDC continues to provide technical guidance to partners to ensure TB/HIV collaborative activities are strengthened. Between October 2016 and September 2017, CDC supported partners screened about 477,921 people living with HIV for TB signs and symptoms; 4,452 TB patients were diagnosed with HIV and placed on ART HIV therapy. (PEPFAR Nigeria, 2017)
TB Infection Prevention and Control: CDC scaled up a comprehensive TB infection control program called TB BASICS across all PEPFAR supported facilities in Nigeria. The ongoing TB BASICS program helps protect healthcare workers and patients from healthcare-associated infection from TB and other airborne infection, and the MOH has incorporated TB BASICS into the national TB/HIV training modules for Healthcare workers.
National AIDS Impact & Indicator Survey (NAIIS): CDC, through its implementing partner University of Maryland (UMB), is carrying out the largest HIV impact survey (target sample size = 170,000) in the country’s history to measure HIV burden and viral suppression nationally and at each of Nigeria 36 states and the Federal Capital Territory.
CDC study provides new evidence that Drug-Resistant Tuberculosis is set to rise in some of the world’s highest burden countries and suggests that it will increasingly be transmitted from Person to Person